In this Open Heart sdy C Jespersen et al found that more than 90% of patients with cLQTS remained attached to the 👷👩‍💻👨‍💼 workforce 1️⃣ year after diagnosis, which was similar to a matched ↔️ background pop bit.ly/3yPaLN8 #cardiotwitter #Cardiology

In this nationwide study, torsades de pointes risk drug use increased in the time leading up to OHCA and was associated with reduced likelihood of presenting with a shockable rhythm and ROSC in an all-comer OHCA setting. 🔗 bit.ly/3Pk2iqc #ResusTwitter

Medical student Lucas Malta Westergaard just presented his study which suggest a clinical benefit of ablation for AF among 🙍🏼‍♀️🙎🏽‍♂️with HF meassured on HF hospitalizations 🏥, furosemide treatment 💊, and NYHA class at #ESCCongress Peter Weeke #RigsHeart

It was a great honor to present my ressearch project at the ESC Congress 2022 in a session with Dr. Douglas L. Packer and Dr. Karl-Heinz Kuck! Thanks to my supervisor Peter Weeke and all the co-authors that have contributed to the project! #ESCCongress RigsHeart 🫀🚨 Copenhagen Cardiovascular Research Center

PeterKJacobsen from RigsHeart 🫀🚨 giving a nice talk 👏 on New insights on ablation #Pfa #HPSD ⚡️⚡️🔥🔥@NordicEPSymposium in Helsinki #Biosense #EPeeps German Bertolo Nevret Mahmudovski Peter Weeke Morten Lock Hansen @MRuwald

Check out our new paper in European Society of Cardiology Journals Europace on #thyroiddysfunction after initiation of #amiodarone led by rising star Sam Ayad Ali in a Danish nationwide cohort #CardioTwitter #Cardiology

💔 Goodbye, Luca.

📢 Patients with BrS are recommended to avoid drugs that increases their risk of arrhythmic events. But what does the follow up really show?? Don't miss this GREAT work by Camilla HB Jespersen 👌 So happy to be a part of this! Peter Weeke prof Jacob Tfelt-Hansen Bo Gregers Winkel ahajournals.org/doi/10.1161/JA…

Medical student @Gylling123 presenting his research for the first time at this years @EHRA2023 in #Barcelona🇪🇸🫀supervised by prof. prof Jacob Tfelt-Hansen and dr. Peter Weeke 👏🏻👏🏻

The findings of the present registry-based study by dr. Lucas Malta Westergaard suggest that a lenient rate control approach aimed lower than recommended by current guidelines and is associated with better outcomes ☠️ among rate-control treated patients presenting with atrial fibrillation🫀

#EUROPACE_FRESH_OFF_THE_PRESS For rate control in AF: ≥100 bpm was associated with greater risk of both new-onset HF and all-cause mortality. 📖 academic.oup.com/europace/advan… #EUROPACE European Society of Cardiology Journals Marco Vitolo Ⓜ️ Francesco Santoro, MD, PhD Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC Giulio Conte Dominik Linz

Great work Camilla HB Jespersen et al!!

Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study 👉 doi.org/10.1093/europa… Dominik Linz Giulio Conte Francesco Santoro, MD, PhD Marco Vitolo Ⓜ️ Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC

Huge congrats to Camilla HB Jespersen on a great 💪 PhD defense today, on Life after a primary arrhythmia diagnosis 👏🎉🏆😍 🙏 to the assessment committee Morten Lock, Kristina Haugaa and Hanno Tan for exiting discussion. prof Jacob Tfelt-Hansen ERN GUARD-Heart Peter Weeke RigsHeart 🫀🚨 Rigshospitalet

📢Exciting research by Krøll et al. in European Society of Cardiology Journals reveals that CRT demonstrates comparable effectiveness in improving #HF outcomes among immigrants and non-immigrants. However, immigrants received CRT at a significantly younger age, yet both groups had equal mortality rates🫀

⚡️Fresh off the Press #Europace Long-term outcomes among immigrants and non-immigrants in cardiac resynchronization therapy. #CRT Insight from 🇩🇰Danish nationwide registries. 🧐👉doi.org/10.1093/europa… Giulio Conte Marco Vitolo Ⓜ️ Francesco Santoro, MD, PhD Dominik Linz Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC

🔁 RT if you think 🇩🇰 mads pedersen is the Super-combative of the #TDF2023! 🔁 RT si vous pensez que 🇩🇰 mads pedersen est le Super-combatif du #TDF2023 !

❗Symptomatic BrS disease manifestation was significantly associated with new-onset depression or anxiety ❗ Did you reach our latest study on this Europace Editor-in-Chief? Great work by Camilla HB Jespersen 👏 @kr_johanna Bo Gregers Winkel prof Jacob Tfelt-Hansen Peter Weeke EHRAPresident #EHRA_ESC #ePeeps

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t